INTRODUCTION
Endocytosed proteins can be directed along different cellular pathways to different fates depending on the cell type and the ligand [1] . In the case of transferrin, the protein is endocytosed, delivers iron to the endosome intracellularly and is subsequently recycled to the cell surface and released as apotransferrin without any permanent changes in the protein structure [2, 3] . In contrast, some protein hormones, such as insulin [4] and epidermal growth factor [5] , are proteolytically processed very rapidly following endocytosis. Other ligands such as lowdensity lipoproteins [1] or asialoglycoproteins [6] [7] [8] are dissociated from their receptors after internalization and routed to a lysosomal compartment to be degraded, while the receptor is recycled to the cell surface and reutilized. In these latter cases the ligand appears to remain intact for up to [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] min in many cell types prior to the, appearance of degradation products.
Hepatocytes endocytose and process internalized asiolo-orosmucoid (ASOR) by two parallel and distinct pathways [8] . These two pathways are associated with two functionally distinct surface galactosyl (Gal) receptor populations that have different thermal and kinetic properties. Table 1 summarizes the characteristics that distinguish and define these two receptor pathways. For example, the total cell surface Gal receptor activity can vary depending on the conditions. One subpopulation of receptors present on the cell surface, designated State 24 and 37°C [9] . The other subpopulation of receptors on the cell surface is not modulated by these treatments and is designated the State 1 Gal receptor population. In both pathways receptor-ASOR complexes are endocytosed and subsequently dissociate so that ligands can be routed to lysosomes while the receptor is recycled to the cell surface. Although the rate of internalization is the same in both pathways, receptorligand dissociation after internalization and ligand de- livery to lysosomes proceeds at very different rates [10] [11] [12] . State 2 receptor-ASOR complexes rapidly dissociate (k = 0.28 min-'), while State 1 complexes dissociate slowly (k = 0.0 14 min-'). The dissociation rate for State 1 receptor-ASOR complexes is much slower than the internalization rate. Therefore, during continuous endocytosis the surface and intracellular State 1 [8] . In this study we examined the effects of various inhibitors to determine if degradation of '25I-labelled ASOR in both Gal receptor pathways occurs by similar mechanisms.
EXPERIMENTAL Materials
Human orosomucoid (ml acid glycoprotein), obtained from Sigma Chemical Co., was desialylated with neuraminidase and iodinated as described [15] Seglen [16] with several modifications as described previously [12] . Final [9] . The cells at 37°C were chilled to 4°C by adding an equal volume of ice-cold Medium 1 and placing them on ice for 10 min. Hepatocytes were then centrifuged, resuspended in Medium 1/BSA plus 1.5 jtg of 'l25-ASOR/ml, incubated for 60 min at 4°C, and then washed three times by centrifugation with ice-cold Hanks' to remove non-bound radioactivity. Endocytosis of 125I-ASOR was initiated by transferring the cell suspensions to 37 'C. When necessary, endocytosis was determined by adding an equal volume of ice-cold Medium 1/EDTA and incubating the cells for 10 min at 4 'C. The cells were then washed three times with Hanks', and internalization was assessed by measuring the amount of cell-associated radioactivity that was not released by EDTA.
The rate of '25I-ASOR degradation was measured as the increase in acid-soluble radioactivity with time [15] . Samples of cell suspensions were mixed with equal volumes of ice-cold 10 % phosphotungstic acid in 2 M-HCI. After at least 15 min on ice, the precipitates were centrifuged at 3000 rev./min (rav = 13 cm) for 10 min and radioactivity in the supernatant fluids was determined. Approx. 99 % of intact '25I-ASOR is precipitated, while free iodide and iodotyrosine remain in solution under these conditions. In the dose-response experiments, each point represents the steady-state rate of degradation of surface-bound 125I-ASOR. Each slope (rate) was calculated by least-squares linear regression analysis of four to five kinetic data points. The average of all correlation coefficients in these determinations was > 0.96. Rates were calculated as (increase in acid soluble radioactivity)/(time), and were normalized within an experiment to the control rate of degradation (set to 1000 in the absence of inhibitor).~0 Experiments using inhibitors to block proteolysis, microtubule function, or to disrupt pH or ion gradients, followed a similar protocol. Cells containing surfacebound 125I-ASOR were incubated with the inhibitor for 10 min at 4°C before transferring the cells to 37 'C. Stock solutions of 25 mM-leupeptin and 40 mM-chloroquine (both in PBS), and 20 mM-colchicine, 20 mmlumicolchicine and 1 mM-monensin (all in dimethyl sulphoxide) were prepared and stored at -20 'C.
General
Protein was determined by the method of Bradford [17] . Centrifugations were at 800 rev./min (rav = 13 cm) for 2 min in a refrigerated centrifuge (Beckman model TJ-6 table-top). 125I radioactivity was determined using a Packard Multiprias 2 gamma spectrometer. Cell incubations were in Erlenmeyer flasks in a gyratory water bath shaking at 100 rev./min at densities of 3 x 106 cells/ml. One flask was used per time point, and the starting times for the incubations were staggered so that all flasks finished together.
RESULTS
When freshly isolated hepatocytes are incubated at 37°C for 1 h, they increase their surface Gal receptor activity 2-4-fold when compared with cells that have been kept on ice [9] . In order to discuss these two situations and relate the properties of Gal receptors on these isolated hepatocytes we have used the following nomenclature [ 
ASOR degradation
The rate of degradation of surface-bound "12 -ASOR was determined as described in the legend to Fig. 1 Ca2" was present during the '25I-ASOR binding step so that Ca2"-activated cell surface proteases cannot be ruled out. Cells were also washed at 4 'C with a pH 5.0 buffer to release possible receptor-bound proteases on the cell surface. After the low-pH stripping, the rate of surface-bound 125I-ASOR degradation by State 1 cells was increased ( Table 2) . Treatment of cells with EDTA or low pH at 4 'C exposes cryptic Gal receptors and increases the amount of 125I-ASOR prebound to the cell surface [8] and its subsequent degradation. Regardless, the immediate degradation of 1251I-ASOR in the State 1 pathway was not inhibited by prior low-pH or EDTA stripping of cell surface proteins.
The State 1 degradation process was also not blocked by up to 1 mM-bacitracin ( were taken at the indicated times, chilled to 4°C, washed in medium 1/EDTA to remove surface-bound ligand, and cell-associated radioactivity was determined. Acid-soluble radioactivity in parallel samples was determined as described in the Experimental section.
glutathione-dependent proteases on the cell surface [21] . The amount of degradation due to soluble or released proteases was tested by incubating cells at 37°C for 3 h, removing the cells by centrifugation and then incubating 1251-ASOR with the conditioned medium at 37 'C. No significant proteolysis was detected by this mechanism.
Effect of chloroquine on 1251-ASOR degradation
Chloroquine is an acidotropic amine that neutralizes acidic intracellular compartments and interferes with normal ligand processing [22] . Chloroquine does not inhibit the endocytosis of surface-bound 125I-ASOR in State 2 rat hepatocytes but does completely stop ligand dissociation [8] . State 1 cells treated with 10 mM-chloroquine showed no release of 1251-ASOR degradation products (Fig. 3b) . A substantial amount of the initial cell-associated radioactivity is lost from untreated State 1 cells by 90 min and appears in the media as degradation products (Fig. 3a) . that both degradation pathways have very similar sensitivity to the inhibitor (Fig. 4) .
Effect of monensin on 125I-ASOR degradation
Monensin is an ionophore that mediates an electroneutral exchange of Na+/K+ for H+ across membranes and can disrupt these ion gradients and the dissociation of internalized receptor-ligand complexes [23] . Dissociation is an obligatory step before ligand degradation in class II recycling receptor systems [24] . Monensin blocked '25I-ASOR degradation mediated by both State 1 and State 2 cells in a similar manner in a narrow concentration range between 2 and 8 /tM (Fig. 5) . However, a small but significant difference was observed in the sensitivities of the two pathways, particularly in the region of 2-4 /sM-monensin. The State 2 pathway was more sensitive than the State 1 pathway (Fig. 5a ). 125-ASOR degradation in the State 2 pathway was essentially completely blocked by 3.5 ,uM-monensin, whereas degradation in the State 1 pathway was largely unaffected (Fig. 5b) .
Effect of coichicine on 125I-ASOR degradation
Delivery of ligand to lysosomes is often sensitive to colchicine and other microtubule depolymerizing drugs that will therefore indirectly inhibit degradation of ligand Vol. 262 The rates of degradation of surface-bound 125I-ASOR were determined as described in Fig. 1 and receptor recycling [25] . The effect of colchicine on 1251-ASOR degradation in State 2 cells (Fig. 6a) showed a biphasic titration curve, whereas the State 1 cells (Fig.  6b) (Fig. 6) . DISCUSSION We previously hypothesized that the Gal receptor system in isolated hepatocytes involves two parallel pathways for ligand processing and receptor recycling [8, 11] . The evidence in support of this two-pathway model is summarized in Table 1 . Ultimately, in either pathway, internalized ligand (125I-ASOR) is degraded to the level of amino acids and monosaccharides within a lysosomal compartment, while the receptor is spared destruction, presumably bypasses the lysosome and returns to the cell surface [7, 8, 26] . In a previous study we demonstrated that under conditions of a synchronous wave of internalization, the bound ligand is dissociated by two kinetically distinct processes [10] . Starting with one round of endocytosis of surface-bound 125I-ASOR, the rate of ASOR degradation is a first-order process that is directly dependent on the number of active surface Gal receptors [12] . Surprisingly, approx. 25-50 % of the endocytosed 125I-ASOR was degraded immediately after internalization without a lag period. The remaining 125I1 ASOR was degraded following a lag of 15-30 min. Earlier studies by other investigators [20, 27, 28] as well as this laboratory [25] demonstrated that the intracellular transport of the majority of internalized asialoglycoproteins to lysosomes requires between 15 and 30 min. However, all of these studies employed conditions of continuous ligand uptake.
The proportion of surface-bound 125I-ASOR degraded by either the immediate-phase or the delayed-phase pathways [12] was dependent on the relative expression of two functionally distinct populations of Gal receptors on the cell surface, previously designated as State 1 and State 2 receptors [11] . We interpret the different onset times for ligand degradation as the transit times for ligand delivery to different lysosomal compartments in the two different pathways. These previous degradation studies have shown that there are different pathways for delivery of ligand to a lysosomal compartment(s). The objective in the present study was to determine whether these two degradative pathways displayed the same sensitivity to a variety of inhibitors that block degradation ofinternalized proteins. Both Gal receptor pathways apparently require the ligand to be in or pass through a low pH compartment prior to degradation. The simplest explanation is that lysosomal function requires an acidic pH. This conclusion is based on the observation that both chloroquine and monensin, which collapses intracellular pH gradients, inhibit degradation of '25I-ASOR in both pathways. Chloroquine destroys the low pH gradient in acidic compartments such as lysosomes and endosomes [29] . In the presence of chloroquine 1251I-ASOR is internalized but then is not dissociated from either State 1 or State 2 Gal receptors and is not degraded. Both the State 1 and State 2 pathways are similarly sensitive to chloroquine.
Monensin can disrupt both Na+ and H+ gradients and also increases the pH of intracellular organelles [30] . Monensin does not inhibit the endocytosis of surfacebound 1251-ASOR in either the State 1 or the State 2 pathway [31] . Degradation of 1251I-ASOR in both Gal receptor pathways was sensitive to monensin. There was a slight but significant difference which might reflect the presence of discrete endosome/lysosome populations dedicated to different endocytosis pathways [27, [32] [33] [34] . The State 2 degradative pathway was more sensitive to inhibition by monensin than the State 1 pathway. In a previous study [31] , we showed that monensin blocks dissociation of internalized 1251-ASOR from State [27] . The major pathway for endocytosis and degradation of asialoglycoproteins is mediated by the State 2 Gal receptor population and probably accounts for 80 % of the steady-state rate of ligand processing [8] . Colchicine (1 /tM) blocks continuous steady-steady 1251-ASOR uptake and degradation by 80 % [25] . The effects of colchicine are not unique and are also found with other microtubule drugs such as vinblastine sulphate, colcemide and podophyllotoxin. Lumicolchicine does not cause an inhibition. Similar studies by others using colchicine also typically show a residual insensitive degree of degradation ranging from 10-20 % of the control steady-state degradative rate. The colchine-resistant degradation is probably due to the State 1 Gal receptor pathway.
The results do not support the idea that the source of the proteolytic activity responsible for degrading the internalized '25I-ASOR in either of the two Gal receptor pathways is a cell surface protease. In particular, removal of surface proteins by treatment with pH 5.0 or EDTAcontaining buffers or use of the surface protease inhibitor bacitracin [21] did not diminish the no-lag State 1 degradation process. Degradation is probably due to an intracellular protease residing in a low pH compartment. Delivery of the internalized ligand to the compartments with the protease(s) requires a pH gradient and/or the protease requires low pH for activity.
The present results provide further evidence for the two-pathway model to explain how the hepatic Gal receptor system functions [8, 11] Vol. 262
